Come up with a name for your new list and we'll add to it:
CUTISS raised a round of funding on May 18, 2017. Investors include
W.A. de Vigier Stiftung.
CUTISS can bioengineer large quantities of personalized skin, beginning from a small biopsy taken from a discreet location, for skin transplantation during surgical intervention. Scarring after transp…